Orphazyme
Signal active
Investment Firm
Overview
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse). Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Highlights
Founded
2009
Industry
Biotechnology
Employees
51-100
Investment
1
Lead Investment
1
Exits
1
Stages
N/A
Investor Type
N/A
Location
Europe
Contact Information
Social
Profile Resume
Orphazyme, established in 2009 and headquartered in Europe., specializes in investments across . Their recent investments include . Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
N/A
investments
1
Diversity investments
0
Lead investments
1
Number of exits
1
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Feb 21, 2024 | - | - | null |
Exits
1
Funding Timeline
Funding rounds
1
Investors
9
Funds
0
Funding Rounds
1
Orphazyme has raised 1 rounds. Their latest funding was raised on Feb 21, 2024 from a Post-IPO Equity - CombiGene round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Feb 21, 2024 | Post-IPO Equity - CombiGene | - | 0 | - |
Investors
24
Orphazyme is funded by 24 investor(s). Sunstone Life Science Ventures and Idinvest Partners Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
EQT Life Sciences | No | Venture Round - Orphazyme | 94.2M |
Idinvest Partners | No | Venture Round - Orphazyme | 94.2M |
Sunstone Life Science Ventures | No | Venture Round - Orphazyme | 94.2M |
| - | No | Post-IPO Equity - Orphazyme | 109.1M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.